Table 2. Data from the Psychometric Assessments and Side-Effect Rating Scales in Patients who Received Haloperidol, on Days 1 and 6 of the Study.

Scale		GG (N = 70)		GA (N = 30)		P*
Day 1
PANSS		14.50 [13.00; 18.00]		16.00 [15.00; 18.00]		0.017
SAS		0 [0; 0]		0 [0; 0]		> 0.999
UKU		0 [0; 0]		0 [0; 0]		> 0.999
Day 6
PANSS		1.00 [1.00; 2.00]		2.00 [1.00; 2.75]		0.006
SAS		11.00 [9.00; 14.00]		14.50 [12.00; 18.00]		< 0.001
UKU		8.00 [7.00; 10.00]		15.00 [9.25; 18.00]		< 0.001

Note: p* – p-value obtained in Benjamini–Hochberg multiple testing correction (based on the results of Mann–Whitney U test).